Rebif for Multiple Sclerosis
Links shared publicly online about this topic
Doctors Alleged to Have Been Paid to Prescribe Multiple Sclerosis Drug Rebif
disabled-world.com — “Allegations a company caused false or fraudulent claims to be submitted to the Medicaid program” View full resource at disabled-world.com
Most Recently Shared on May 13, 2011 at 10:25 pm By:
Disabled World Health Advocate and Health News
Doctors Alleged to Have Been Paid to Prescribe Multiple Sclerosis Drug Rebif http://ff.im/-DiXm7
Multiple Sclerosis Head-to-Head Study Comparing TYRABRI To Copaxone And Rebif
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) today announced enrollment of the first patient in a global Phase IIIb, randomized, rater-blinded, active-controlled study designed” View full resource at medicalnewstoday.com
Most Recently Shared on March 26, 2010 at 4:10 pm By:
MNT Clinical Trials Health News
Multiple Sclerosis Head-to-Head Study Comparing TYRABRI To Copaxone And Rebif http://mnt.to/3ztw #clinicaltrials
Lemtrada Better At Preventing MS Relapses Than Rebif, But Not At Reducing Disability Risk
medicalnewstoday.com — “Although Lemtrada (alemtuzumab) was found to be more effective in preventing MS relapses than the older drug - Rebif - it did not prevent multiple sclerosis (MS) from becoming disabling in a late-” View full resource at medicalnewstoday.com
Most Recently Shared on July 11, 2011 at 7:05 pm By:
Lemtrada Better At Preventing MS Relapses Than Rebif, But Not At Reducing Disability Risk http://mnt.to/3Y8Z #multiplesclerosis
Is rebif a good medication for MS? Can anyone tell me about it? - Multiple Sclerosis
healthcentral.com — “I just found out I have MS and I am thinking about taking this medication. ...” View full resource at healthcentral.com
Most Recently Shared on July 15, 2011 at 4:26 pm By:
HealthCentral Tips Health Site
@Kitty_Catrelli Another person had the same question and here is the opinion of a woman taking rebif http://bit.ly/n6Oqp1
Genzyme MS drug shines in head-to-head trial with Rebif | InPharm
inpharm.com — “Genzyme--™s multiple sclerosis candidate Lemtrada has impressed in a new phase II head-to-head trial” View full resource at inpharm.com
Most Recently Shared on April 18, 2011 at 9:53 am By:
Pharmafocus Health News and Pharma
Genzyme MS drug shines in head-to-head trial with Rebif http://goo.gl/fb/6yK45
PharmaLive: Merck Serono: CHMP Gives Positive Opinion for Extended Indication for Rebif to Treat Patients With Early Signs of Multiple Sclerosis
pharmalive.com — “PharmaLive: Merck Serono: CHMP Gives Positive Opinion for Extended Indication for Rebif to Treat Patients With Early Signs of Multiple Sclerosis” View full resource at pharmalive.com
Most Recently Shared on November 18, 2011 at 6:00 pm By:
PharmaLive Pharma and Health News
#Merck #Serono: CHMP Gives Positive Opinion for Extended Indication for Rebif to Treat Patients w/Early Signs of #MS: http://t.co/pCuGHH16
REFLEX Study Results Show Treatment with Rebif Delays Conversion to MS in Patients with First Clinical Signs of the Disease - Drugs.com MedNews
drugs.com — “Study met its primary endpoint Risk of converting to multiple sclerosis (McDonald criteria) was reduced by half in patients treated with Rebif 44 mcg three time” View full resource at drugs.com
Most Recently Shared on October 25, 2010 at 2:12 pm By:
Drugs and Devices OW OW Health
REFLEX Study Results Show Treatment with Rebif Delays Conversion to MS in Patients with First Clinical Signs ... http://bit.ly/bzTgZJ #drug
Experimental MS Drug Outperforms Standard Treatment
webmd.com — “Nearly 71% of people with early relapsing-remitting multiple sclerosis (MS) treated with the an experimental MS drug showed no evidence of disease activity four years into a study, researchers report.” View full resource at webmd.com
Most Recently Shared on April 15, 2010 at 11:01 pm By:
webMD: Experimental MS Drug Outperforms Standard Treatment http://bit.ly/9N5ciT Full http://bit.ly/biUmki
: Merck Serono: REFLEX Study Results Show Treatment With Rebif(R) Delays Conversion to MS in Patients With First Clinical Signs of the Disease | wallstreet:online
wallstreet-online.de — “GENEVA, October 25, 2010 /PRNewswire/ - Study Met its Primary Endpoint - Risk of Converting to Multiple Sclerosis (McDonald Criteria) Was Reduced by Half in Patients Treated With Rebif(R) 44 mcg Three Times a Week Merck Serono, a division of ...” View full resource at wallstreet-online.de
Most Recently Shared on October 25, 2010 at 1:38 pm By:
Merck Serono: REFLEX Study Results Show Treatment With Rebif(R) Delays Conversion to MS in Patients With First ...... http://bit.ly/bV9uRH
Multiple Sclerosis - Mediitation for Multiple Sclerosis
healthcentral.com — “Meditation and yoga can be beneficial to those of us with MS. Meditation is a contemplative mental exercise for complete relaxation or awareness.” View full resource at healthcentral.com
Most Recently Shared on May 19, 2010 at 7:03 pm By:
Yoga and Meditation for Multiple Sclerosis ... http://dld.bz/ege8
Multiple Sclerosis - Parenting with Multiple Sclerosis
healthcentral.com — “It isn't supposed to be this way is it? You are the parent and have children to take care of. Yet now you are faced with this disease and you wonder if in time your kids will be taking care of you.” View full resource at healthcentral.com
Most Recently Shared on December 9, 2009 at 3:31 pm By:
Parenting with Multiple Sclerosis … http://short.to/zsp5
Is MS Hereditary? - Multiple Sclerosis
healthcentral.com — “Like many people when first diagnosed with MS, I asked the question, --Will my children get MS?-- I was told no. That was 20 years ago. Is that still the case?” View full resource at healthcentral.com
Most Recently Shared on March 21, 2011 at 4:45 pm By:
HealthCentral Tips Health Site
Research indicates men with MS are 2x as likely as women with MS to pass it on to their children. http://bit.ly/f9tUbv Is MS hereditary?
Data of focusing on Rebif and Cladribine Tablets to be presented at AAN Annual Meeting
news-medical.net — “EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that new data from the company's multiple sclerosis portfolio of approved and investigational treatments will be presented at the 62nd Annual Meeting of the American Academy of Neurology taking place April 10 to 17, in Toronto, Canada.” View full resource at news-medical.net
Most Recently Shared on April 1, 2010 at 12:09 pm By:
Pregnancy News: Data of focusing on Rebif and Cladribine Tablets to be presented at AAN Annual Meeting: EMD Serono... http://bit.ly/d8ysYj
Gilenya (fingolimod), first MS oral drug, will be available in US with financial help from Novartis - Multiple Sclerosis
healthcentral.com — “Even before I was diagnosed with MS in 2005, I researched the different treatment options. I learned about the ABC’s (Avonex, Betaseron, Copaxone),...” View full resource at healthcentral.com
Most Recently Shared on October 5, 2010 at 8:30 pm By:
Gilenya (fingolimod), first MS oral drug, will be available in US with financial help from Novartis http://ow.ly/19iRvv
Multiple Sclerosis
nlm.nih.gov — “Multiple Sclerosis” View full resource at nlm.nih.gov
Most Recently Shared on August 27, 2009 at 11:58 pm By:
@sweetyliza32 Liza, Multiple Sclerosis or MS is a medical condition: http://j.mp/cuXjlm
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Disabled World
Disabled World is managed by Lynn and Ian Langtree, a couple dedicated to assisting seniors and people with disabilities.
-
MNT Clinical Trials
The latest clinical trials news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Multiple Scl
The latest multiple sclerosis news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
